These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3124015)

  • 1. Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man.
    Casanueva FF; Burguera B; Tome MA; Lima L; Tresguerres JA; Devesa J; Dieguez C
    Neuroendocrinology; 1988 Jan; 47(1):46-9. PubMed ID: 3124015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man.
    Burguera B; Muruais C; Peñalva A; Dieguez C; Casanueva FF
    Neuroendocrinology; 1990 Jan; 51(1):51-8. PubMed ID: 2106087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
    Peñalva A; Burguera B; Casabiell X; Tresguerres JA; Dieguez C; Casanueva FF
    Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
    Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive injections of growth hormone releasing hormone (GHRH1-44) to normal volunteers and patients with growth hormone deficiency.
    Hümmelink R; Sippell WG
    Horm Metab Res; 1990 Feb; 22(2):101-8. PubMed ID: 2182500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY; Granda-Ayala R
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG; Macfarlane P; Levitt NS; Millar RP
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency.
    Giustina A; Bresciani E; Bossoni S; Chiesa L; Misitano V; Wehrenberg WB; Veldhuis JD
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1266-72. PubMed ID: 7962318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.
    Vance ML; Kaiser DL; Evans WS; Thorner MO; Furlanetto R; Rivier J; Vale W; Perisutti G; Frohman LA
    J Clin Endocrinol Metab; 1985 Feb; 60(2):370-5. PubMed ID: 3917460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP; Corder R; Pralong FP; Gaillard RC
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent inhibition of growth hormone (GH)-releasing hormone-induced GH release by corticotropin-releasing hormone in prepubertal children.
    Ghizzoni L; Vottero A; Street ME; Bernasconi S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1397-400. PubMed ID: 8636340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone responses to continuous infusions of growth hormone-releasing hormone.
    Gelato MC; Rittmaster RS; Pescovitz OH; Nicoletti MC; Nixon WE; D'Agata R; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Aug; 61(2):223-8. PubMed ID: 3924946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men.
    Evans WS; Vance ML; Kaiser DL; Sellers RP; Borges JL; Downs TR; Frohman LA; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1985 Nov; 61(5):846-50. PubMed ID: 3930551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longtime administration of growth hormone-releasing hormone (GHRH) does not restore the reduced efficiency of GHRH on sleep endocrine activity in 2 old-aged subjects--a preliminary study.
    Murck H; Frieboes RM; Schier T; Steiger A
    Pharmacopsychiatry; 1997 Jul; 30(4):122-4. PubMed ID: 9271777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.